| Autor: |
Paglia G; Department of Biochemical Sciences 'Alessandro Rossi Fanelli', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Antonini L; Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Cervoni L; Department of Biochemical Sciences 'Alessandro Rossi Fanelli', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Ragno R; Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Sabatino M; Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Minacori M; Department of Biochemical Sciences 'Alessandro Rossi Fanelli', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy., Rubini E; Department of Biochemical Sciences 'Alessandro Rossi Fanelli', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy.; Enrico ed Enrica Sovena Foundation, 00199 Rome, Italy., Altieri F; Department of Biochemical Sciences 'Alessandro Rossi Fanelli', Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy. |
| Abstrakt: |
In a previous work, it was shown that punicalagin, an active ingredient of pomegranate, is able to bind to PDIA3 and inhibit its disulfide reductase activity. Here we provide evidence that punicalagin can also bind to PDIA1, the main expressed form of protein disulfide isomerase (PDI). In this comparative study, the affinity and the effect of punicalagin binding on each protein were evaluated, and a computational approach was used to identify putative binding sites. Punicalagin binds to either PDIA1 or PDIA3 with a similar affinity, but the inhibition efficacy on protein reductase activity is higher for PDIA3. Additionally, punicalagin differently affects the thermal denaturation profile of both proteins. Molecular docking and molecular dynamics simulations led to propose a punicalagin binding mode on PDIA1 and PDIA3, identifying the binding sites at the redox domains a' in two different pockets, suggesting different effects of punicalagin on proteins' structure. This study provides insights to develop punicalagin-based ligands, to set up a rational design for PDIA3 selective inhibitors, and to dissect the molecular determinant to modulate the protein activity. |
